Results 181 to 190 of about 1,917,255 (320)
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Sustainable and accessible hemodialysis: life cycle assessment on central acid delivery system. [PDF]
Tsai CL +5 more
europepmc +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Insights from Life Cycle Assessment to Inform Chemical Substitution, Alternatives Assessment and Safe and Sustainable-by-Design. [PDF]
Fantke P, Mankong P.
europepmc +1 more source
Life Cycle Assessment of Spring Frost Protection Methods: High and Contrasted Environmental Consequences in Vineyard Management [PDF]
Vincent Baillet +2 more
openalex +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Commentary: Non-linearity in LCA – What are we talking about?
Reinout Heijungs +3 more
doaj +1 more source
A Systematic Review of Nutraceuticals from the Perspective of Life-Cycle Assessment. [PDF]
Djekic I, Smigic N, Vitali Čepo D.
europepmc +1 more source

